Core Points - NewGenIvf Group Limited clarified that it has not yet achieved compliance with Nasdaq's $2.5 million minimum stockholders' equity requirement, although it believes it has exceeded this amount due to recent debt conversions and equity line drawdowns [1][2] - The Nasdaq Hearings Panel granted NewGen an extension to regain compliance with listing requirements, and the company has made progress, including a reverse stock split to meet the $1.00 bid price requirement [2] - NewGen operates as a comprehensive fertility services provider in Asia, with clinics in Thailand, Cambodia, and Kyrgyzstan, offering a range of infertility treatments and services [3]

Core Points - Hyzon Motors Inc. intends to delist its Class A common stock and publicly-traded warrants from the Nasdaq Stock Market, with a Form 25 expected to be filed around March 4, 2025 [1][3] - Following the delisting, the common stock may be traded on the OTC Markets Group Inc., although there are no guarantees for this transition [2] - The Board of Directors has decided to deregister the company with the SEC, believing that both delisting and deregistration serve the best interests of the company and its shareholders [3][4] Delisting Details - The delisting decision follows a determination letter from Nasdaq, which cited the company's previously announced Plan of Dissolution and public interest concerns [5] - The company's securities were suspended from trading on Nasdaq starting January 30, 2025, due to this delisting notification [5] Company Overview - Hyzon Motors specializes in high-performance hydrogen fuel cell technology aimed at providing zero-emission power for decarbonizing heavy-duty commercial vehicles and other demanding industries [6]

Core Insights - Diginex Limited has announced its shares are now cross-listed on the Frankfurt Stock Exchange and Tradegate Exchange, effective February 20, 2025, aiming to enhance global investor reach and liquidity [1][3] - The company has engaged Kirchhoff Consult GmbH to lead a European investor engagement initiative, which is expected to diversify its investor base and improve stock trading resilience [2][4] - The cross-listing follows a successful IPO on Nasdaq, which closed on January 23, 2025, positioning Diginex to attract a broader range of institutional and retail investors [3] Company Overview - Diginex Limited is a Cayman Islands-based impact technology company focused on environmental, social, and governance (ESG) issues, with operations in Hong Kong, the UK, and the USA [5] - The company operates through its subsidiary Diginex Solutions (HK) Limited, which provides software solutions for ESG, climate, and supply chain data collection and reporting [5][6] - Diginex's technology utilizes blockchain, machine learning, and data analysis to address pressing ESG and sustainability challenges [5]

The first full month of 2025 is in the books, and the stock market is off to a decent start. The major indexes -- the S&P 500, Nasdaq Composite, and Dow Jones Industrial Average -- were up 2.7%, 1.6%, and 4.7%, respectively.In a change of pace from previous months, the Nasdaq took a back seat to the Dow, as sectors like financial services, energy, and industrials outperformed tech. Nevertheless, there were plenty of big winners in the Nasdaq-100. Here are the top five performers during the month of January. ...

MIAMI and TORONTO, Feb. 19, 2025 /PRNewswire/ -- Sekur Private Data Ltd. (OTCQB: SWISF) (CSE: SKUR) (FRA: GDT0) ("Sekur" or the "Company"), a leading Swiss-hosted cybersecurity and privacy communications platform, releases a shareholder update from its CEO, Mr. Alain Ghiai, providing a comprehensive review of 2024 achievements and a bold outlook for 2025.Dear Shareholders,2024 has been a remarkable year for Sekur, driven by our innovative, Swiss-hosted secure communications platform. Designed to shield indi ...

EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...

Kraft Heinz has been named as the '’Top Dividend Stock of the Nasdaq 100’’, according to Dividend Channel, which published its most recent ''DividendRank'' report. The report noted that among the components of the Nasdaq 100 index, KHC shares displayed both attractive valuation metrics and strong profitability metrics. For example, the recent KHC share price of $28.92 represents a price-to-book ratio of 0.7 and an annual dividend yield of 5.5% — by comparison, the average dividend paying stock in the Nasdaq ...

XIAMEN, China, Feb. 18, 2025 /PRNewswire/ -- Lichen China Limited (Nasdaq: LICN) ("Lichen China" or the "Company"), a dedicated financial and taxation service provider in China today announced that it has received a letter from The Nasdaq Stock Market LLC ("Nasdaq"), notifying that the Company is not in compliance with Nasdaq Listing Rule 5810(c)(3)(A)(iii) (the "Low Priced Stocks Rule"), as the Company's securities had a closing bid price of $0.10 or less for eleven consecutive trading days from January 28 ...

The Nasdaq Composite is one of the U.S. stock market's three major indexes, tracking almost every stock on the Nasdaq stock exchange.The Nasdaq-100 is a subset of the Nasdaq Composite that tracks the largest 100 nonfinancial companies on the Nasdaq stock exchange, and investing in it is one of the more popular ways to invest in the Nasdaq. It's much more concentrated than the Nasdaq Composite, but that has worked out in its favor.If you have $2,000 available to invest (meaning an emergency fund saved and hi ...

Core Points - Oncolytics Biotech Inc. received a delinquency notification from Nasdaq due to its ordinary shares closing below $1.00 for 30 consecutive business days, which is a violation of Nasdaq's minimum bid price requirement [1][2] - The company has until August 12, 2025, to regain compliance with the minimum bid price requirement, during which its shares will continue to trade on Nasdaq [2][3] - If the company fails to regain compliance by the deadline, it may be eligible for additional time to meet the listing requirements, provided it meets other criteria [3] Company Overview - Oncolytics Biotech Inc. is a clinical-stage biotechnology company focused on developing pelareorep, an immunotherapeutic agent for cancer treatment [4] - Pelareorep has shown promising results in clinical studies for metastatic breast cancer and pancreatic cancer, and it works by inducing anti-cancer immune responses [4][5] - The company is conducting combination clinical trials with pelareorep and has received Fast Track designation from the FDA for its studies in metastatic breast cancer and pancreatic cancer [5]